Trial
NCT01996696
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
AHS Cancer Control Alberta
Collaborators
—
Condition
Prostatic Neoplasm
Intervention
Metformin
Why stopped
Results of interim analysis indicate no statistically significant difference in the primary objective between the two arms at baseline and 12 months of follow-up.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-30